Healthcare Sector Articles Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame Keywords June 21, 2026 8:30 AM ET3 Biotech Firms With Major Potential Catalysts in the Coming MonthsNathan ReiffNASDAQ:KRYSNASDAQ:ADMANASDAQ:VERARead 3 Biotech Firms With Major Potential Catalysts in the Coming MonthsJune 20, 2026 6:45 AM ET3 Non-Pharma Firms That Could Benefit From the GLP-1 TrendNathan ReiffNYSE:TDOCNASDAQ:OLLINASDAQ:DXCMRead 3 Non-Pharma Firms That Could Benefit From the GLP-1 TrendJune 20, 2026 6:10 AM ETBeyond the AI Trade: 3 Defensive Stocks Built for StabilityThomas HughesNYSE:UNHNASDAQ:AEPNYSE:BNRead Beyond the AI Trade: 3 Defensive Stocks Built for StabilityJune 18, 2026 7:30 AM ET3 Stocks Doing the Heavy Lifting in Healthcare’s ReboundJessica MitacekNYSE:HUMNYSE:LLYNASDAQ:DXCMRead 3 Stocks Doing the Heavy Lifting in Healthcare’s ReboundJune 15, 2026 7:50 AM ETHealthcare Added 35,200 Jobs—3 Stocks Positioned to BenefitChris MarkochNYSE:UNHNYSE:HCANYSE:EHCRead Healthcare Added 35,200 Jobs—3 Stocks Positioned to BenefitJune 14, 2026 8:00 AM ETWhat to Expect From Q2 Earnings as Tech Strength BroadensThomas HughesNASDAQ:NVDANASDAQ:GOOGLNASDAQ:METARead What to Expect From Q2 Earnings as Tech Strength BroadensJune 11, 2026 10:25 AM ETPatent Cliff Predators: GSK Acquires Nuvalent For $10.6 BillionJeffrey Neal JohnsonNASDAQ:NUVLNYSE:GSKNYSE:PFERead Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 BillionJune 8, 2026 5:40 AM ET3 Longevity ETFs to Buy and Hold (and Hold)Nathan ReiffNYSEARCA:XBINYSEARCA:BMEDNASDAQ:AGNGRead 3 Longevity ETFs to Buy and Hold (and Hold)June 7, 2026 6:45 AM ET3 ETFs For the Coming Genomics RevolutionNathan ReiffBATS:ARKGBATS:HELXNYSEARCA:IDNARead 3 ETFs For the Coming Genomics RevolutionJune 4, 2026 11:10 AM ETMedtronic Bottoms, Healthy Rebound AheadThomas HughesNYSE:MDTNASDAQ:MMEDRead Medtronic Bottoms, Healthy Rebound AheadJune 2, 2026 9:15 AM ETEli Lilly Wins Back CVS Health, Reverting Novo's AdvantageLeo MillerNYSE:LLYNYSE:NVONYSE:CVSRead Eli Lilly Wins Back CVS Health, Reverting Novo's AdvantageJune 1, 2026 12:20 PM ETWhy These Three Big Buybacks Are Sending Very Different Signals to InvestorsLeo MillerNYSE:RBLXNYSE:PWRNYSE:BSXRead Why These Three Big Buybacks Are Sending Very Different Signals to InvestorsMay 31, 2026 5:45 AM ET5 Best Growth Stocks for the Next 10 YearsChris MarkochNYSE:TSMNASDAQ:AVGONYSE:NVORead 5 Best Growth Stocks for the Next 10 YearsMay 28, 2026 9:00 AM ETIs Co-Diagnostics National Security’s Next Diagnostic Pick?Jeffrey Neal JohnsonNASDAQ:OSURNASDAQ:CODXNASDAQ:GOVXRead Is Co-Diagnostics National Security’s Next Diagnostic Pick?May 28, 2026 7:15 AM ETHims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?Jessica MitacekNYSE:HIMSNYSE:NVONYSE:LLYRead Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?May 24, 2026 6:50 AM ETAmylyx Stock: Why the Full Pipeline Story MattersChris MarkochNASDAQ:AMLXNASDAQ:REGNNYSE:MRKRead Amylyx Stock: Why the Full Pipeline Story MattersMay 23, 2026 5:50 AM ETKiniksa Pharmaceuticals Still Has Room to Run After 100% RallyChris MarkochNASDAQ:KNSARead Kiniksa Pharmaceuticals Still Has Room to Run After 100% RallyMay 21, 2026 9:40 AM ETThe Silver Lining of Last Week's Hims & Hers Earnings MissJessica MitacekNYSE:HIMSNYSE:NVORead The Silver Lining of Last Week's Hims & Hers Earnings MissMay 20, 2026 12:55 PM ETFrom Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 OutlookLeo MillerNYSE:LLYNYSE:NVORead From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 OutlookMay 18, 2026 6:55 AM ETThese Stocks Could Be the Biggest Winners of the 2026 MidtermsChris MarkochNYSE:LMTNYSE:RTXNYSEARCA:XLVRead These Stocks Could Be the Biggest Winners of the 2026 MidtermsMay 12, 2026 11:00 AM ETHims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?Jessica MitacekNYSE:HIMSNYSE:NVORead Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?May 10, 2026 6:50 AM ET3 Healthcare Stocks Set to Benefit From the One Big Beautiful BillChris MarkochNYSE:UNHNYSE:HUMNYSE:CVSRead 3 Healthcare Stocks Set to Benefit From the One Big Beautiful BillMay 8, 2026 9:10 AM ETHims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusJessica MitacekNYSE:HIMSNYSE:NVORead Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusMay 7, 2026 8:05 AM ETWhat the FDA's Latest Proposal Means for Lilly, Novo, and HimsLeo MillerNYSE:LLYNYSE:NVONYSE:HIMSRead What the FDA's Latest Proposal Means for Lilly, Novo, and HimsMay 5, 2026 10:25 AM ET3 Reasons Analysts Love DexComNathan ReiffNASDAQ:DXCMNYSE:MDTRead 3 Reasons Analysts Love DexComMay 2, 2026 6:45 AM ETThe Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the BeatJessica MitacekNYSE:ABBVNYSE:AZNNYSE:GSKRead The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the BeatMay 1, 2026 11:05 AM ETLilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentNathan ReiffNYSE:LLYNYSE:NVORead Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentMay 1, 2026 8:45 AM ETViking Therapeutics Faces Timeline Risk—But Upside Could Be HugeChris MarkochNASDAQ:VKTXNYSE:LLYNYSE:NVORead Viking Therapeutics Faces Timeline Risk—But Upside Could Be HugeApril 29, 2026 12:50 PM ETAbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?Thomas HughesNYSE:ABBVNYSE:ABTRead AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?April 28, 2026 7:55 AM ETAmazon Takes a Bite Out of Hims: What Its GLP-1 Entrance MeansLeo MillerNYSE:HIMSNYSE:LLYNYSE:NVORead Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance Means Page 1 of 2 12 Earlier › More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCommunication Services SectorCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingInvestor EducationIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorUtilities SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
